Clearpoint Neuro Stock Piotroski F Score

CLPT Stock  USD 10.93  0.31  2.76%   
This module uses fundamental data of Clearpoint Neuro to approximate its Piotroski F score. Clearpoint Neuro F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Clearpoint Neuro. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Clearpoint Neuro financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Clearpoint Neuro Altman Z Score, Clearpoint Neuro Correlation, Clearpoint Neuro Valuation, as well as analyze Clearpoint Neuro Alpha and Beta and Clearpoint Neuro Hype Analysis.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.
  
At this time, Clearpoint Neuro's Short Term Debt is comparatively stable compared to the past year. Net Debt To EBITDA is likely to gain to 0.46 in 2024, whereas Long Term Debt is likely to drop slightly above 8.3 M in 2024. At this time, Clearpoint Neuro's Research And Ddevelopement To Revenue is comparatively stable compared to the past year. Capex To Revenue is likely to gain to 0.05 in 2024, whereas Operating Cash Flow Per Share is likely to drop (0.59) in 2024.
At this time, it appears that Clearpoint Neuro's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Increase

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

Increase

Focus

Clearpoint Neuro Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Clearpoint Neuro is to make sure Clearpoint is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Clearpoint Neuro's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Clearpoint Neuro's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.690.5615
Fairly Up
Slightly volatile
Gross Profit Margin0.750.5683
Significantly Up
Slightly volatile
Total Current Liabilities4.7 M7.4 M
Way Down
Slightly volatile
Non Current Liabilities Total9.6 M14.1 M
Way Down
Slightly volatile
Total Assets23.2 M42.7 M
Way Down
Slightly volatile
Total Current Assets20.4 M36.2 M
Way Down
Slightly volatile

Clearpoint Neuro F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Clearpoint Neuro's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Clearpoint Neuro in a much-optimized way.

About Clearpoint Neuro Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

0.9

At this time, Clearpoint Neuro's Book Value Per Share is comparatively stable compared to the past year.

Clearpoint Neuro Current Valuation Drivers

We derive many important indicators used in calculating different scores of Clearpoint Neuro from analyzing Clearpoint Neuro's financial statements. These drivers represent accounts that assess Clearpoint Neuro's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Clearpoint Neuro's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap63.1M251.9M232.6M204.8M167.1M83.6M
Enterprise Value59.9M256.0M190.8M189.2M157.9M165.8M

Clearpoint Neuro ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Clearpoint Neuro's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Clearpoint Neuro's managers, analysts, and investors.
Environmental
Governance
Social

About Clearpoint Neuro Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.